(Q33621327)

28 July 2017

title

Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival (English)

1 reference

28 July 2017

1 reference

8

John K Wiencke

1 reference

28 July 2017

13

Daphne A Haas-Kogan

1 reference

28 July 2017

10

Michael D Prados

1 reference

28 July 2017

12

David Stokoe

1 reference

28 July 2017

Sean M McBride

1

1 reference

28 July 2017

Daniel A Perez

2

1 reference

28 July 2017

Mei-Yin Polley

3

1 reference

28 July 2017

Scott R Vandenberg

4

1 reference

28 July 2017

Justin S Smith

5

1 reference

28 July 2017

Shichun Zheng

6

1 reference

28 July 2017

Kathleen R Lamborn

7

1 reference

28 July 2017

Susan M Chang

9

1 reference

28 July 2017

Mitchel S Berger

11

1 reference

28 July 2017

publication date

25 August 2009

1 reference

Journal of Neuro-Oncology

28 July 2017

published in

1 reference

28 July 2017

volume

97

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

33-40

1 reference

mTOR-understanding the clinical effects.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814032

The role of mTOR in the management of solid tumors: an overview

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814032

Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814032

Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814032

Therapeutic targets: MTOR and related pathways

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814032

The TOR pathway: a target for cancer therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814032

Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814032

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814032

Role of S6 phosphorylation and S6 kinase in cell growth

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814032

Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814032

The impact of mTOR inhibitors on the development of malignancy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814032

The changing management of low-grade astrocytomas and oligodendrogliomas

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814032

Prognostic and survival-related factors in patients with well-differentiated oligodendrogliomas

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814032

Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814032

EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814032

Alterations of the TP53 gene in human gliomas

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814032

10.1007/S11060-009-0004-4

30 October 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference